Sumitomo Dainippon Pharma Aktie
| 4,90EUR | -0,35EUR | -6,67% |
WKN: 858257 / ISIN: JP3495000006
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Personal am Ende des Jahres | 6 457 | 6 822 | 6 987 | 6 250 | 4 980 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 74,76 | 75,63 | 80,15 | 88,89 | 63,16 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Summe Umlaufvermögen | 364 090 | 459 795 | 499 521 | 381 860 | 269 569 | 253 168 |
| Summe Anlagevermögen | 844 744 | 871 250 | 892 432 | 753 121 | 583 927 | 474 901 |
| Summe Aktiva | 1 252 878 | 1 308 127 | 1 308 007 | 1 134 742 | 907 506 | 742 604 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 315 259 | 290 680 | 284 544 | 346 372 | 427 864 | 305 422 |
| Summe Fremdkapital | 620 773 | 659 949 | 634 438 | 727 960 | 751 370 | 573 125 |
| Summe Eigenkapital | 632 105 | 648 178 | 673 569 | 406 782 | 156 136 | 169 479 |
| Summe Passiva | 1 252 878 | 1 308 127 | 1 308 007 | 1 134 742 | 907 506 | 742 604 |
Adresse
| 2-6-8 Dosho-machi, 541-0045 Osaka | |
| Telefon | +81 (6) 6203-5321 |
| Fax | +81 (6) 6202-6028 |
| Internet | http://www.ds-pharma.co.jp/ |
Management
|
Hiroshi Niinuma
Non-Executive Director |
|
Hiroyuki Baba
Managing Executive Officer & Head-Legal Affairs |
|
Hisayoshi Kashima
Manager-Accounting |
|
Isao Shimizu
Executive Officer & Senior Research Director |
|
Kazuo Koshiya
Managing Executive Officer |
|
Kenji Ueno
Executive Officer & GM-Technology Research |
|
Koji Fujimoto
Outside Director |
|
Minoru Usui
Outside Director |
|
Motoyuki Sakai
Representative Director & VP-Governance |
|
Nobuhiro Endo
Independent Outside Director |
|
Saeko Arai
Independent Outside Director |
|
Shigeyuki Nishinaka
Managing Executive Officer |
|
Takashi Kutsunai
Auditor |
|
Takuya Taguchi
Managing Executive Officer & General Manager-Sales |
|
Toru Kimura
President, CEO & Representative Director |
|
Tsutomu Nakagawa
Director & Managing Executive Officer |
|
Yoshiharu Ikeda
Head-Research & Technology |
|
Yoshinori Ooe
Auditor |
|
Yutaka Wakemi
Executive Officer, VP & Head-Global Strategy |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
